CAPR
Capricor Therapeutics (CAPR)
$34
About Capricor Therapeutics (CAPR)
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.
Details
Daily high
$30.19
Daily low
$28.89
Price at open
$29.50
52 Week High
$40.37
52 Week Low
$4.30
Market cap
1.6B
Dividend yield
0.00%
Volume
1.8M
Avg. volume
936,872
P/E ratio
-12.27
Capricor Therapeutics News
Details
Daily high
$30.19
Daily low
$28.89
Price at open
$29.50
52 Week High
$40.37
52 Week Low
$4.30
Market cap
1.6B
Dividend yield
0.00%
Volume
1.8M
Avg. volume
936,872
P/E ratio
-12.27